IBT specializes in delivering top-notch reagents tailored for research and development purposes.
An animal model is a non-human species used in biomedical research because it can mimic aspects of a biological process or disease found in humans.
Disease-to-target discovery is the process of identification and early validation of targets involved in a disease.
IBT specializes in comprehensive preclinical testing services aimed at assessing the safety and efficacy of potential treatments and vaccines against Streptococcus pneumonia . Diseases Pneumonia, Bacteremia, and meningitis Infects Elderly, young children, and immunocompromised humans Symptoms Fever, cough, chills, shortness of breath, chest pain, and in some cases, mental confusion, disorientation. Bacterial Characteristics Streptococcus pneumonia […]
Staphylococcus aureus At IBT Bioservices, we understand the critical need for effective interventions against Staphylococcus aureus infections. We specialize in comprehensive preclinical testing services aimed at assessing the safety and efficacy of potential treatments and vaccines against this versatile and often antibiotic-resistant bacterium. Diseases Skin and Soft Tissue Infections (SSTI’s), Pneumonia, and Bacteremia Infects Elderly, […]
Ebola Virus Disease Our team at IBT Bioservices has extensive experience in preclinical testing services to assess the viability and effectiveness of novel therapies against filorviruses including Ebola and Marburg viruses Our comprehensive range includes Pseudoviruses specifically tailored for neutralization assays Antibodies essential for detection in ELISA and Western blotting Virus-like particles and glycoproteins Rest […]
In Vitro & In Vivo Dengue Animal Models CRO Services to Support Pre-clinical Research Our team at IBT Bioservices has extensive experience in preclinical testing services to assess the viability and effectiveness of novel therapies against arboviruses including Chikungunya, Dengue, and Zika viruses. CAUSED BY infected female Aedes mosquitoes, particularly Aedes aegypti or Aedes albopictus […]
In Vitro & In Vivo Zika Virus Animal Models to Support Pre-clinical Research Our team at IBT Bioservices has extensive experience in preclinical testing services to assess the viability and effectiveness of novel therapies against arboviruses including chikungunya, dengue, and Zika viruses. CAUSED BY Zika virus, transmitted via bites of infected Aedes mosquitoes, particularly Aedes […]
In Vitro & In Vivo Influenza Preclinical CRO Services to Support Pre-clinical Research Our team at IBT Bioservices has extensive experience in preclinical testing services to assess the viability and effectiveness of novel therapies against respiratory illnesses such as RSV, influenza, SARS-CoV-2 through animal models and cell-based assays. REagents 7 Recombinant Proteins 2 Pseudoviruses In-Vitro […]
In Vitro & In Vivo RSV Cotton Rat Models to Support Pre-clinical Research Our team at IBT Bioservices has extensive experience in preclinical testing services to assess the viability and effectiveness of novel therapies against respiratory illnesses such as RSV, influenza, SARS-CoV-2. Transmission RSV is highly contagious and spreads through respiratory droplets when an infected […]
MARBURG VIRUS DISEASE Our team at IBT Bioservices, a leading preclinical CRO, has extensive experience in preclinical testing services to assess the viability and effectiveness of novel therapies against filorviruses including Ebola and Marburg viruses CAUSED BY Marburg virus, which can cause severe and often fatal illness TRANSMISSION Marburg virus is transmitted to humans from bats […]
